Immutrin Ltd
- Company number
- 12217886
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 20 Sep 2019
- Nature of business
- Research and experimental development on biotechnology
Registered office
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| SINHA, Nihal | Director | 2 Feb 2026 | |
| KURSTJENS, Sef Paul, Dr | Director | 1 Feb 2025 | |
| TUNA CLARKE, Mihriban, Dr | Director | 6 Feb 2024 | |
| ANSTEY, Michael Leith | Director | 3 Dec 2019 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Cambridge Innovation Capital Limited | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
31 Mar 2022 | 10 Feb 2026 |
| Professor Mark Brian Pepys | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
20 Sep 2019 | 31 Mar 2022 |
| Daniel Christ | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
20 Sep 2019 | 3 Dec 2019 |
| Sir Gregory Paul Winter | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
20 Sep 2019 | 3 Dec 2019 |
Accounts
| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 31 Aug 2025 | - | £550,931 | 6 |
| 31 Aug 2024 | £744,955 | £730,429 | 4 |
| 31 Aug 2023 | £1,805,179 | £1,600,302 | 0 |
| 31 Aug 2022 | - | £178,115 | 0 |
| 31 Aug 2021 | - | £145,915 | 0 |
| 31 Aug 2020 | - | £247,096 | 0 |